# Protalix BioTherapeutics, Inc.: Form 8-K, filed Oct 12, 2021

- Company: [Protalix BioTherapeutics, Inc.](/companies/plx.md) (CIK 1006281)
- Form: 8-K
- Filed: 2021-10-12
- Accepted by EDGAR: Oct 12, 2021, 06:03 ET
- Period: 2021-10-11
- Accession: 0001558370-21-013109
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1006281/000155837021013109/plx-20211011x8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1006281/000155837021013109/

## Items reported

- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1006281/000155837021013109/plx-20211011x8k.htm

Filed Oct 12, 2021.
Source: SEC EDGAR, the filing index for accession 0001558370-21-013109. Last ingested by Listed: Nov 10, 2026, 16:48 ET. No prices; not investment advice.
